Athersys

Wider-Than-Expected Loss at Athersys

Wider-Than-Expected Loss at Athersys

Yahoo/Zacks

Does Cell Therapy Hold The Key To Treating Stroke?

Does Cell Therapy Hold The Key To Treating Stroke?

Seeking Alpha

Athersys Has Some Promise, But Controversy And Doubt Remain

Athersys Has Some Promise, But Controversy And Doubt Remain

Seeking Alpha

Athersys, Inc: The Facts

Athersys, Inc: The Facts

Seeking Alpha

Athersys

Investing In The Stem Cell Sector: An Overview

Investing In The Stem Cell Sector: An Overview

Seeking Alpha

Athersys' MultiStem Platform Tempts Big Pharma And Investors

Athersys' MultiStem Platform Tempts Big Pharma And Investors

Seeking Alpha

Stem Cell Therapy Companies: Underappreciated Outperformers

Stem Cell Therapy Companies: Underappreciated Outperformers

Seeking Alpha

Athersys Should Gain At Least 50%

Athersys Should Gain At Least 50%

Seeking Alpha

4 Biotechs That Just Got Mauled By Bears

4 Biotechs That Just Got Mauled By Bears

Seeking Alpha

Pfizer's Pipeline Could Push Stock 20% Higher By 2014

Pfizer's Pipeline Could Push Stock 20% Higher By 2014

Seeking Alpha